November 2021 marks another grim flashpoint in a stream of them: the global COVID-19 death toll surpassed five million. The rapid development of vaccines has been an extraordinary achievement in the fight against COVID-19. However, successfully vaccinating the global population, especially in low-income countries, has been hampered by several challenges – notably vaccine inequity and weak health systems.
28 September 2021, Cape Town/Geneva – H3D-Foundation (H3D-F) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced today a three-year partnership to strengthen capacity for health innovation in Africa. The two organizations will combine forces to focus on driving capacity strengthening for drug discovery and development in Africa by scaling existing initiatives and identifying new development opportunities for young and mid-career scientists in the region.
H3D and Ersilia OSI are excited to co-present a Drug Discovery Course by Dr Miquel Duran-Frigola entitled "Data driven drug discovery based on machine learning and large-scale bioactivity experiments". The event is this Friday 3 September, 12:00 – 13:00 SAST.
We will discuss, how machine learning techniques originally developed for text and image analysis, have the potential to revolutionize the drug discovery field.
Event details in attached flyer here.
Join the meeting here
This National Women’s Month, we sat down with Dr Lauren Arendse, one of H3D’s female trailblazers, to “Spill the T” on what it’s like to be a female leader in science.
“Being a small part of a bigger shared vision to train scientists and build drug discovery capabilities in Africa, and seeing the progress unfolding, is extremely rewarding and gives meaning to what I do.”